TCT-168 TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold implantation for recovery of vascular function after successful Chronic Total Occlusion recanalization
At linear mixed model, CBF exhibited significantly higher values in the Ticagrelor as compared to Clopidogrel group during multiple stepwise adenosine infusion, even after adjustment for age (p=0.029; Figure 1). Conclusion The TIGER BVS trial showed that Ticagrelor may be efficacious in improving co...
Saved in:
Published in | Journal of the American College of Cardiology Vol. 70; no. 18; p. B72 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Elsevier Inc
31.10.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | At linear mixed model, CBF exhibited significantly higher values in the Ticagrelor as compared to Clopidogrel group during multiple stepwise adenosine infusion, even after adjustment for age (p=0.029; Figure 1). Conclusion The TIGER BVS trial showed that Ticagrelor may be efficacious in improving coronary vascular flow in CTO patients as compared to Clopidogrel. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2017.09.235 |